Advertisement

Coronavirus: Mexico to test 2,000 doses of Russia’s ‘Sputnik’ vaccine

Click to play video 'Coronavirus: Trump questions Russia’s COVID-19 vaccine credibility' Coronavirus: Trump questions Russia’s COVID-19 vaccine credibility
WATCH: Trump questions Russia’s COVID-19 vaccine credibility

Mexico will receive at least 2,000 doses of Russia’s potential COVID-19 vaccine, dubbed ‘Sputnik V’, to test among its population, a senior Mexican government official said on Thursday.

“Mexico was offered at least 2,000 doses of the vaccine to do its protocol to start testing it in Mexico, which is very good news because again we buy ourselves time,” said Mexican Foreign Minister Marcelo Ebrard.

Read more: ‘Vaccine nationalism’ will make the coronavirus pandemic worse, WHO says

On Wednesday, Mexico’s government told Moscow it would like to carry out phase 3 testing of the vaccine, as part of the Latin American country’s efforts to secure early supplies of an effective medicine to control the coronavirus pandemic.

Click to play video 'Is herd immunity possible before a vaccine is made?' Is herd immunity possible before a vaccine is made?
Is herd immunity possible before a vaccine is made?

Mass testing of Russia’s COVID-19 vaccine to get domestic regulatory approval will involve more than 40,000 people and will be overseen by a foreign research body when it starts next week, backers of the project said on Thursday.

Story continues below advertisement

The vaccine has been dubbed “Sputnik V” in homage to the world’s first satellite launched by the Soviet Union.

Click to play video 'Coronavirus: Dr. Fauci says COVID-19 vaccine should not be mandatory' Coronavirus: Dr. Fauci says COVID-19 vaccine should not be mandatory
Coronavirus: Dr. Fauci says COVID-19 vaccine should not be mandatory

The government of President Andres Manuel Lopez Obrador is angling to have a working vaccine as soon as possible in Mexico.

His administration has already agreed to help manufacture a vaccine candidate being developed by Britain’s AstraZeneca and Oxford University to supply the Latin American market.

It is also preparing to carry out late-stage trials for U.S. company Johnson & Johnson and two Chinese companies.

Mexico has registered 537,031 known coronavirus cases and 58,481 deaths, the third highest death tally in the world.